All In Biotech

Drug Trial Radar · NCT02613195

Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation

Hydrogen-Rich Celsior Solution Improve the Quality of Aging DBD Grafts in Liver/Kidney Transplantation: Prospective, Randomized Clinical Trial

Last checked: Nov 20, 2026Latest source record: Nov 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 2016

Primary completion

Feb 2017

Study completion Feb 2017

Sponsor

Lead sponsor
RenJi HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 24, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 60 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether hydrogen-rich Celsior solution improve the quality of aging grafts in liver/kidney transplantation.

Conditions

  • Evidence of Liver Transplantation

Interventions

  • Hydrogen-Rich Celsior SolutionDrug

    Before the procedure, add hydrogen gas into Celsior solution. After harvesting the liver/kidney grafts, lavage and cold store the grafts with Hydrogen-Rich Celsior Solution.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Aspartate Aminotransferase(AST)/Alanine Aminotransferase(ALT)Time frame: up to 6 months
  2. Change From Baseline in direct bilirubin(DBil)/total bilirubin(TBil)Time frame: up to 6 months
  3. Change From Baseline in creatinineTime frame: up to 6 months
  4. Change From Baseline in glomerular filtration rate(GFR)Time frame: up to 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

    Shanghai, China

  • Ren Ji Hospital

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.